Table 2: Cardiopulmonary exercise testing parameters at rest and exercise between Pre and Post EPO treatment
| Pre | Post | P value | |
| At Rest | |||
| Rest HR, (bpm) | 88.2 ± 18.2 | 84.8 ± 13.1 | 0.362 |
| Rest SBP, (mmHg) | 148.5 ± 24.7 | 141.0 ± 18.9 | 0.147 |
| Rest VE, (l/min) | 9.4 ± 2.2 | 8.7 ± 1.7 | 0.110 |
| Rest R-R, (n/min) | 16.3 ± 4.0 | 16.9 ± 4.2 | 0.510 |
| Rest TV, (ml) | 617.1 ± 228.4 | 566.8 ± 187.6 | 0.304 |
| Rest VO2, (ml/min) | 202.9 ± 42.1 | 207.7 ± 36.2 | 0.604 |
| Rest VCO2, (ml/min) | 172.2 ± 41.5 | 165.5 ± 31.4 | 0.436 |
| Rest VE/VO2, (ml/ml) | 46.9 ± 6.4 | 43.8 ± 5.5 | 0.028 |
| Rest VE/VCO2 , (ml/ml) | 55.6 ± 8.1 | 55.2 ± 8.1 | 0.824 |
| Rest VCO2/VO2 | 0.85 ± 0.05 | 0.80 ± 0.05 | < 0.001 |
| During Exercise | |||
| Exercise time, (sec.) | 467.8 ± 154.4 | 584.5 ± 145.6 | < 0.001 |
| Peak HR, (bpm) | 125.5 ± 27.7 | 121.6 ± 27.5 | 0.548 |
| Peak SBP, (mmHg) | 186.1 ± 29.7 | 183.9 ± 29.4 | 0.755 |
| Peak VE, (l/min) | 32.8 ± 12.8 | 33.1 ± 12.2 | 0.919 |
| Peak R-R, (n/min) | 27.8 ± 7.1 | 28.9 ± 7.1 | 0.492 |
| Peak TV, (ml) | 1181.2 ± 362.5 | 1148.7 ± 335.6 | 0.690 |
| AT, (mL/min/kg) | 12.3 ± 2.8 | 13.3 ± 2.5 | 0.153 |
| AT time, (sec.) | 393.1 ± 66.0 | 449.4 ± 86.8 | < 0.05 |
| ΔVO2/time, (mL/min/sec) | 1.91 ± 1.03 | 1.67 ± 0.31 | 0.178 |
| Peak O2 pulse, (mL/min/beat) | 6.5 ± 2.1 | 8.1 ± 2.1 | 0.001 |
| Peak VO2, (ml/min/kg) | 15.7 ± 5.3 | 18.8 ± 5.3 | 0.017 |
| OUES | 1,255 ± 375 | 1,517 ± 357 | < 0.001 |
| VE vs. VCO2 slope | 34.3 ± 7.3 | 31.8 ± 7.2 | 0.861 |
| Peak VCO2/VO2 | 0.97 ± 0.12 | 0.90 ± 0.13 | 0.026 |